Skip to main content
. 2021 Oct 27;148(2):387–400. doi: 10.1007/s00432-021-03841-x

Table 2.

Evaluation of the resection specimens comparing the three age groups pre-, peri- and post-screening, divided by the used treatment concept

Total Total no neoadjuvant therapy No neoadjuvante therapy p-value Total neoadjuvant therapy Neoadjuvant therapy p-value
Pre-screening (< 50 years) Peri-screening (50–69 years) Post-screening (≥ 70 years) Fisher´s exact test Pre-screening (< 50 years) Peri-screening (50–69 years) Post-screening (≥ 70 years) Fisher´s exact test
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
ICD-M (grouped) 2.886 2.453 0.000 433 0.062
 Invasive carcinoma not specified 1.886 (65.3) 1.569 (64.0) 330 (67.2) 760 (64.4) 479 (61.3) 317 (73.2) 161 (74.9) 127 (70.2) 29 (78.4)
 Lobular carcinoma not specified 425 (14.7) 358 (14.6) 49 (10.0) 167 (14.1) 142 (18.2) 67 (15.5) 28 (13.0) 36 (19.9) 3 (8.1)
 Medullary carcinoma not specified. atypical medullary carcinoma 56 (1.9) 40 (1.6) 15 (3.1) 15 (1.3) 10 (1.3) 16 (3.7) 9 (4.2) 7 (3.9) 0 (0.0)
 Tubular adenocarcinoma 42 (1.5) 39 (1.6) 7 (1.4) 22 (1.9) 10 (1.3) 3 (0.7) 3 (1.4) 0 (0.0) 0 (0.0)
 Intraductal papillary adenocarcinoma with invasion 17 (0.6) 16 (0.7) 1 (0.2) 7 (0.6) 8 (1.0) 1 (0.2) 0 (0.0) 0 (0.0) 1 (2.7)
 Metaplastic carcinoma not specified 10 (0.3) 9 (0.4) 1 (0.2) 3 (0.3) 5 (0.6) 1 (0.2) 0 (0.0) 1 (0.6) 0 (0.0)
 Mucinous carcinoma 44 (1.5) 41 (1.7) 1 (0.2) 11 (0.9) 29 (3.7) 3 (0.7) 2 (0.9) 1 (0.6) 0 (0.0)
 Other subtypes 90 (3.1) 81 (3.3) 9 (1.8) 37 (3.1) 35 (4.5) 9 (2.1) 2 (0.9) 4 (2.2) 3 (8.1)
 In-situ carcinoma 316 (10.9) 300 (12.2) 78 (15.9) 159 (13.5) 63 (8.1) 16 (3.7) 10 (4.7) 5 (2.8) 1 (2.7)
pT category 2.887 2.454 0.000 433 0.037
 T0 81 (2.8) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 81 (18.7) 43 (20.0) 35 (19.3) 3 (8.1)
 Tis 321 (11.1) 301 (12.3) 77 (15.7) 160 (13.6) 64 (8.2) 20 (4.6) 12 (5.6) 6 (3.3) 2 (5.4)
 T1mi 15 (0.5) 13 (0.5) 4 (0.8) 7 (0.6) 2 (0.3) 2 (0.5) 1 (0.5) 1 (0.6) 0 (0.0)
 T1a 112 (3.9) 81 (3.3) 19 (3.9) 36 (3.0) 26 (3.3) 31 (7.2) 21 (9.8) 10 (5.5) 0 (0.0)
 T1b 407 (14.1) 375 (15.3) 70 (14.3) 203 (17.2) 102 (13.0) 32 (7.4) 21 (9.8) 9 (5.0) 2 (5.4)
 T1c 1.038 (36.0) 958 (39.0) 175 (35.6) 482 (40.8) 301 (38.5) 80 (18.5) 41 (19.1) 30 (16.6) 9 (24.3)
 T2 726 (25.2) 612 (24.9) 125 (25.5) 257 (21.8) 230 (29.4) 114 (26.3) 51 (23.7) 51 (27.6) 13 (35.1)
 T3 164 (5.7) 98 (4.0) 21 (4.3) 32 (2.7) 45 (5.8) 66 (15.2) 24 (11.2) 36 (19.9) 6 (16.2)
 T4a 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.6) 0 (0.0)
 T4b 13 (0.5) 9 (0.4) 0 (0.0) 2 (0.2) 7 (0.9) 4 (0.9) 1 (0.5) 2 (1.1) 1 (2.7)
 T4d 5 (0.2) 4 (0.2) 0 (0.0) 0 (0.0) 4 (0.5) 1 (0.2) 0 (0.0) 1 (0.6) 0 (0.0)
 TX 4 (0.1) 3 (0.1) 0 (0.0) 2 (0.2) 1 (0.1) 1 (0.2) 0 (0.0) 0 (0.0) 1 (2.7)
rpT-category 2.885 2.453 0.068 432 0.001
 Relapse 92 (3.2) 89 (3.6) 10 (2.0) 44 (3.7) 35 (4.5) 3 (0.7) 0 (0.0) 0 (0.0) 3 (8.3)
 No relapse 2.793 (96.8) 2.364 (96.4) 481 (98.0) 1136 (96.3) 747 (95.5) 429 (99.3) 215 (100) 181 (100) 33 (91.7)
pT(m)-category 2.566 2.153 0.489 413 0.966
 Multiple lesions 320 (12.5) 283 (13.1) 57 (13.8) 125 (12.2) 101 (14.1) 37 (9.0) 19 (9.4) 15 (8.6) 3 (8.6)
 No multiple lesions 2.246 (87.5) 1.870 (86.9) 357 (86.2) 896 (87.8) 617 (85.9) 376 (91.0) 184 (90.6) 160 (91.4) 32 (91.4)
pN category 2.665 2.239 0.012 426 0.171
 N0 1.871 (70.2) 1.607 (71.8) 305 (68.7) 799 (74.5) 502 (69.7) 264 (62.0) 139 (65.3) 105 (59.7) 20 (54.1)
 N1mi 73 (2.7) 60 (2.7) 18 (4.1) 23 (2.1) 19 (2.6) 13 (3.1) 8 (3.8) 5 (2.8) 0 (0.0)
 N1a 421 (15.8) 339 (15.1) 77 (17.3) 154 (14.4) 108 (15.0) 82 (19.2) 42 (19.7) 31 (17.6) 9 (24.3)
 N1b 1 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.5)
 N1c 2 (0.1) 2 (0.1) 0 (0.0) 0 (0.0) 2 (0.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 N2a 142 (5.3) 97 (4.3) 23 (5.2) 45 (4.2) 29 (4.0) 45 (10.6) 19 (8.9) 22 (12.5) 4 (10.8)
 N3a 77 (2.9) 58 (2.6) 10 (2.3) 18 (1.7) 30 (4.2) 19 (4.5) 5 (2.3) 11 (6.3) 3 (8.1)
 NX 78 (2.9) 75 (3.3) 11 (2.5) 34 (3.2) 30 (4.2) 3 (0.7) 0 (0.0) 2 (1.1) 1 (2.7)
pL category 2.563 2.165 0.002 398 0.118
 L0 2.207 (86.1) 1.887 (87.2) 346 (82.8) 924 (89.6) 617 (86.2) 320 (80.4) 155 (78.7) 141 (84.4) 24 (70.6)
 L1 353 (13.8) 275 (12.7) 72 (17.2) 106 (10.3) 97 (13.5) 78 (19.6) 42 (21.3) 26 (15.6) 10 (29.4)
 LX 3 (0.1) 3 (0.1) 0 (0.0) 1 (0.1) 2 (0.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
pV-categroy 2.563 2.164 0.013 399 1.000
 V0 2.525 (98.5) 2.137 (98.8) 413 (99.0) 1.024 (99.3) 700 (97.8) 388 (97.2) 193 (97.5) 162 (97.0) 33 (97.1)
 V1 37 (1.4) 26 (1.2) 4 (1.0) 6 (0.6) 16 (2.2) 11 (2.8) 5 (2.5) 5 (3.0) 1 (2.9)
 VX 1 (0.0) 1 (0.0) 0 (0.0) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Pn-category 899 706 0.105 193 0.824
 Pn0 832 (92.5) 652 (92.4) 129 (96.3) 254 (90.4) 269 (92.4) 180 (93.3) 90 (92.8) 75 (92.6) 15 (100)
 Pn1 67 (7.5) 54 (7.6) 5 (3.7) 27 (9.6) 22 (7.6) 13 (6.7) 7 (7.2) 6 (7.4) 0 (0.0)
Grading 2.119 2.119 0.000
 G1 481 (22.7) 481 (22.7) 97 (23.7) 241 (24.0) 143 (20.3)
G2 1.251 (59.0) 1.251 (59.0) 209 (51.0) 600 (59.6) 442 (62.9)
 G3 387 (18.3) 387 (18.3) 104 (25.4) 165 (16.4) 118 (16.8)
pR-status 2.863 2.445 0.037 418 0.757
 R0 2.818 (98.5) 2.409 (98.5) 481 (98.2) 1.167 (99.2) 761 (97.7) 409 (97.8) 200 (98.0) 174 (97.8) 35 (97.2)
 R1 27 (0.9) 23 (0.9) 5 (1.0) 7 (0.6) 11 (1.4) 4 (1.0) 2 (1.0) 2 (1.1) 0 (0.0)
 RX 18 (0.6) 13 (0.5) 4 (0.8) 2 (0.2) 7 (0.9) 5 (1.2) 2 (1.0) 2 (1.1) 1 (2.8)